The Ebola virus VP35 protein functions as a type I IFN antagonist

Cited by papers we hold 10

• Animal models for Ebola and Marburg virus infections · 2013
  No notice
• Innate Immunity Evasion by Dengue Virus · 2012
  No notice
• Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus · 2010
  No notice
• The Epidermal Growth Factor Receptor (EGFR) Promotes Uptake of Influenza A Viruses (IAV) into Host Cells · 2010
  No notice
• Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis · 2010
  No notice
• SARS-CoV Pathogenesis Is Regulated by a STAT1 Dependent but a Type I, II and III Interferon Receptor Independent Mechanism · 2010
  No notice
• Ebola Zaire Virus Blocks Type I Interferon Production by Exploiting the Host SUMO Modification Machinery · 2009
  No notice
• Effective Post-Exposure Treatment of Ebola Infection · 2007
  No notice
• The Ebola Virus VP35 Protein Is a Suppressor of RNA Silencing · 2007
  No notice
• Molecular Determinants of Ebola Virus Virulence in Mice · 2006
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.